News

The identification and intervention of Alzheimer's Disease (AD) in its early-stage allows for the timely implementation of lifestyle modifications and therapeutic strategies. Although dysregulation of ...
In this webinar, Benoit Derrien will discuss new strategies using enzymatically synthesized DNA for gene construction.
Decoy Therapeutics, Inc. (Decoy), a privately held preclinical biopharmaceutical company engineering the next generation of peptide conjugate therapeutics, announces that Massachusetts Institute of ...
Researchers from Eli Lilly & Co. reported preclinical data on LY-3954068, a MAPT small-interference RNA (siRNA) strategy in AD models. The therapy is designed to reduce tau protein synthesis by ...
Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) have described a new mechanism ...
Dublin, April 15, 2025 (GLOBE NEWSWIRE) -- The "MRNA Synthesis & Manufacturing Market by Product (Consumables [Transcription, Purification, Analysis ...
A new study from Weill Cornell Medicine provides insights into how cells maintain the tiny end caps of chromosomes as they ...
A team of researchers has uncovered a previously unrecognized role of mitochondrial protein synthesis in the maintenance of intracellular iron distribution. Disruption of this process was found to ...
RNA vaccines train the immune system in a similar way to traditional vaccines, but they use a different strategy to get there ...
Nuclera, the biotechnology company accelerating protein expression and optimization through its benchtop eProtein Discovery™ system, today announced the addition of a new membrane protein workflow to ...